Details for New Drug Application (NDA): 212258
✉ Email this page to a colleague
The generic ingredient in TICAGRELOR is ticagrelor. There are twenty-one drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ticagrelor profile page.
Summary for 212258
| Tradename: | TICAGRELOR |
| Applicant: | Macleods Pharms Ltd |
| Ingredient: | ticagrelor |
| Patents: | 0 |
Pharmacology for NDA: 212258
| Mechanism of Action | Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors P2Y12 Receptor Antagonists |
| Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 212258
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TICAGRELOR | ticagrelor | TABLET;ORAL | 212258 | ANDA | Macleods Pharmaceuticals Limited | 33342-431 | 33342-431-09 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-431-09) |
| TICAGRELOR | ticagrelor | TABLET;ORAL | 212258 | ANDA | Macleods Pharmaceuticals Limited | 33342-431 | 33342-431-12 | 10 BLISTER PACK in 1 CARTON (33342-431-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
| Approval Date: | Oct 28, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 90MG | ||||
| Approval Date: | Oct 28, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
